Business Standard

Tuesday, December 24, 2024 | 01:49 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

India Coronavirus Dispatch: Covaxin not for people on blood thinners

Centre plans to accelerate vaccine drive, Delhi near herd immunity, Indian industry's key role in roll-out-news relevant to India's fight against Covid-19

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma
Premium

Bharath Manjesh New Delhi
17 per cent of Indians between ages 30 and 69 on blood thinners, cannot take Covaxin

At least 17 per cent of Indians between the ages of 30 and 69 years cannot be administered Bharat Biotech’s Covaxin, as the inoculant is not meant for people who use blood thinners, according to a report in ThePrint.

Some 17.4 per cent Indians are on aspirin, a commonly used blood thinner, according to the National Non-Communicable Disease Monitoring Survey 2017-18. Blood thinners are drugs that impede blood coagulation, both within blood vessels and in case of bleeding. Covaxin’s fact-sheet says that people who are on

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in